نتایج جستجو برای: tumor associated antigen

تعداد نتایج: 1998750  

Journal: :BMC Surgery 2021

Abstract Background Cumulating evidence indicates that the systemic inflammatory response (SIR) plays a crucial role in prognosis of various cancers. We aimed to generate preoperative risk grade (PRG) by integrating SIR markers preoperatively predict long-term intrahepatic cholangiocarcinoma (ICC). Methods 468 consecutive ICC patients who underwent hepatectomy between 2010 and 2017 were enrolle...

Journal: :Frontiers in Molecular Medicine 2022

Chimeric antigen receptor (CAR)-T cell therapy represents one of the most innovative immunotherapy approaches. The encouraging results achieved by CAR-T in hematological disorders paved way for employment CAR engineered T cells different types solid tumors. This adoptive a selective and efficacious approach to eradicate tumors through recognition tumor-associated antigens (TAAs). Binding TAAs p...

Journal: :Journal of Immunology 2023

Abstract Glioblastomas are immunologically “cold” tumors with intense immunosuppressive myeloid cell- and sparse cytotoxic T-cell infiltration. Therefore, viral vector vaccines may be a promising approach to boost the induction of glioblastoma-targeted T cells. It has been previously shown that heterologous prime-boost vaccination chimpanzee-derived adenovirus ChAdOx1 modified vaccinia Ankara (...

Journal: :Journal for ImmunoTherapy of Cancer 2021

Background Tumor-associated antigens (TAAs) and especially cancer testis (CTAs) are classical tumor-specific targets for immunotherapies. As TAAs shared between patients, strategies aiming to exploit these scalable potentially applicable across different types of cancer. Loss target other mechanisms immune escape have limited the success CTA-directed immunotherapy. CAR T cells highly effective ...

Ali Badiee Mahmoud Reza Jaafari, Mercedeh Mansourian Seyed Alireza Mortazavi, Seyed Amir Jalali, Sheida Shariat

Objective(s):Tumor-associated antigen (TAA) subunit-based vaccines constitute promising tools for anticancer immunotherapy. However, a major limitation in the development of such vaccines is the poor immunogenicity of peptides when used alone.The aim of this study was to develop an efficient vaccine delivery system and adjuvant to enhance anti-tumor activity of a synthetic HER2/neu derived pept...

2006
Vera S. Byers Alan S. Levin James 0. Johnston Adeline J. Hackett

Tumor-associated antigen was found by reacting sera from two patients with giant cell tumor of bone with cells derived from their tumors, using autologous serum as intermediate reactant and fluorescein-conjugated goat anti human IgG as final reactant. Approximately 40% of the plump, spindle-shaped cells that formed the background stroma of these tumors possessed the antigen; however, it was not...

Antibodies provide a suitable tool in fundamental research and their high affinity and specificity make them invaluable for diagnostic and therapeutic applications. A promising alternative to conventional antibodies are the heavy chain antibodies (VHH) of Camelidae having short length, high solubility and stability are preferred to other antibody derivatives. In this study, our goal was product...

Background: Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule with modulatory effects on NK and T cells. Because HLA-G expression is frequently detected in different solid tumors, it may be involved in tumor immune evasion. Objective: This study was designed to elucidate the prognostic value of HLA-G in hepatocellular carcinoma (HCC) and pancreatic adenocarcinoma (PADC). Th...

Central ossifying fibroma is a benign, slow-growing tumor of mesenchymal origin with a predilection for the mandibular premolar and molar areas. The immunophenotype of T cells involved in the antitumor response against this benign tumor is unknown. In this case report, we described a case of a 48-year-old woman presenting with a very large recurrent ossifying fibroma in the mandible, which was ...

Background: Colorectal cancer is the third most common type of aggressive cancers. Chemotherapy, surgery,and radiotherapy are the common therapeutic options for treating this cancer. Due to the adverse side-eff ects of these methods, immunotherapy is considered as an appropriate alternative therapeutic option. Treatment through the application of monoclonal antibodies is considered as a n...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید